Cumulative corticosteroid exposure (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 49 | 全身性エリテマトーデス | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01616472 (ClinicalTrials.gov) | April 2012 | 7/6/2012 | WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) | WEUKBRE5716: Quantifying the Burden of Steroid-related Damage in Systemic Lupus Erythematosus in the Hopkins Lupus Cohort | Systemic Lupus Erythematosus | Drug: Cumulative corticosteroid exposure | GlaxoSmithKline | NULL | Completed | N/A | N/A | Both | 1 | N/A | NULL |